017: Identification of novel target genes in breast cancer patients, development of sequencing based prognostic and predictive profiles and their transfer into clinics

HIPO Investigator:

Prof. Peter Lichter

Dr. Marc Zapatka

Prof. Andreas Schneeweiss

Prof. Barbara Burwinkel

Supported by: HIPO/POP

Entity: breast cancer


Huang Z et al.; confFuse: High-Confidence Fusion Gene Detection across Tumor Entities; Front Genet. 2017

Kosaloglu, Zeynep, et al. "In silico SNP analysis of the breast cancer antigen NY-BR-1." BMC Cancer 2016


DKFZ Logo 3zu Research en Black Blue sRGB

4c nctlogo 2009

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.